StockData
Xenetic Biosciences, Inc. logo

Xenetic Biosciences, Inc. (XBIO) stock

XBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3064% below fair value
$1.61+0.12 (+8.05%)

Close on Nov 17, 2026Market cap $3.77MP/E –Yield –

Xenetic Biosciences gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2013 it was 100.0%, against 84.7% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2013Dec 31, 2013100.0%+15.3
FY2012Dec 31, 201284.7%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2017Sep 30, 2017-14.2%–

More Xenetic Biosciences figures

See a number that looks wrong?